Cansino Biologics Inc. (6185.HK)
Company Info
ISIN | CNE100003F01 |
---|---|
Sector | Healthcare |
Industry | Drug Manufacturers—Specialty & Generic |
Highlights
Market Cap | HK$13.03B |
---|---|
EPS | -HK$5.77 |
PE Ratio | 134.23 |
Revenue (TTM) | HK$502.83M |
Gross Profit (TTM) | -HK$183.71M |
EBITDA (TTM) | -HK$1.62B |
Year Range | HK$20.50 - HK$95.70 |
Target Price | HK$83.49 |
Share Price Chart
Loading data...
Performance
The chart shows the growth of an initial investment of HK$10,000 in Cansino Biologics Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Compare to other instruments
Return
Cansino Biologics Inc. had a return of -64.64% year-to-date (YTD) and -71.50% in the last 12 months.
Period | Return | Benchmark |
---|---|---|
Year-To-Date | -64.64% | 18.49% |
1 month | -14.80% | 4.20% |
6 months | -17.77% | 6.60% |
1 year | -71.50% | 15.43% |
5 years (annualized) | N/A | 11.59% |
10 years (annualized) | N/A | 9.70% |
Monthly Returns Heatmap
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2023 | -21.56% | -10.14% | 12.24% | -21.64% | 6.09% | 1.43% | 10.30% |
Risk-Adjusted Performance
This table presents a comparison of risk-adjusted performance metrics for Cansino Biologics Inc. (6185.HK) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Sharpe ratio | Sortino ratio | Omega ratio | Calmar ratio | Ulcer Index | |
---|---|---|---|---|---|
6185.HK Cansino Biologics Inc. | -1.27 | ||||
^GSPC S&P 500 | 1.00 |
Dividend History
Cansino Biologics Inc. granted a 0.00% dividend yield in the last twelve months. The annual payout for that period amounted to HK$0.00 per share.
Period | TTM | 2022 |
---|---|---|
Dividend | HK$0.00 | HK$0.94 |
Dividend yield | 0.00% | 1.40% |
Monthly Dividends
The table displays the monthly dividend distributions for Cansino Biologics Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2023 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | |
2022 | HK$0.94 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 |
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the Cansino Biologics Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Cansino Biologics Inc. was 95.12%, occurring on Oct 4, 2023. The portfolio has not yet recovered.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
---|---|---|---|---|---|---|
-95.12% | Feb 18, 2021 | 646 | Oct 4, 2023 | — | — | — |
-47.24% | Aug 3, 2020 | 62 | Nov 2, 2020 | 58 | Jan 25, 2021 | 120 |
-33.66% | May 21, 2020 | 6 | May 28, 2020 | 30 | Jul 13, 2020 | 36 |
-31.39% | Apr 17, 2019 | 33 | Jun 6, 2019 | 117 | Nov 22, 2019 | 150 |
-21.17% | Mar 5, 2020 | 3 | Mar 9, 2020 | 10 | Mar 23, 2020 | 13 |
Volatility Chart
The current Cansino Biologics Inc. volatility is 13.26%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.